CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Treatment of high risk AML and MDS with Ara-C-Containing standard chemotherapy followed by reduced-intensity conditioning allogeneic stem cell transplantation (RIC-SCT) during Aplasia: a survey of the German Cooperative Transplant Study Group (GCTSG)
Author
Bornhaeuser Martin
Dengler Jolanta B.
+8Â more
Dreger Peter
Ehninger Gerhard
Hegenbart Ute
Ho Anthony D.
Kienast Joachim
Schmid Christoph
Stelljes Matthias
Theuser Cathrin
Publication venue
'American Society of Hematology'
Publication date
01/01/2006
Field of study
No full text
OPUS Augsburg